L. Uiso

558 total citations
10 papers, 424 citations indexed

About

L. Uiso is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, L. Uiso has authored 10 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 7 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in L. Uiso's work include Tuberculosis Research and Epidemiology (9 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and Mycobacterium research and diagnosis (4 papers). L. Uiso is often cited by papers focused on Tuberculosis Research and Epidemiology (9 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and Mycobacterium research and diagnosis (4 papers). L. Uiso collaborates with scholars based in United Kingdom, Tanzania and India. L. Uiso's co-authors include Stephen H. Gillespie, N. Kennedy, F.I. Ngowi, Esther Kanduma, Noel E. Sam, Roly Gosling, James L. Gutmann, Emily Bongard, Richard Morris and Mramba Nyindo and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Clinical Infectious Diseases and Journal of Antimicrobial Chemotherapy.

In The Last Decade

L. Uiso

10 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Uiso United Kingdom 9 332 284 126 54 48 10 424
F.I. Ngowi United Kingdom 7 263 0.8× 227 0.8× 114 0.9× 21 0.4× 29 0.6× 10 334
Yew Ww China 9 411 1.2× 369 1.3× 121 1.0× 34 0.6× 35 0.7× 21 561
Ferdinand Kassa Benin 5 270 0.8× 180 0.6× 102 0.8× 34 0.6× 18 0.4× 6 392
Melissa Engle United States 13 584 1.8× 408 1.4× 163 1.3× 132 2.4× 39 0.8× 19 786
Veriko Mirtskhulava Georgia 11 448 1.3× 323 1.1× 167 1.3× 10 0.2× 12 0.3× 17 551
Victoria A. Muggia United States 9 85 0.3× 143 0.5× 60 0.5× 43 0.8× 51 1.1× 15 292
Lindsey H. M. te Brake Netherlands 10 262 0.8× 153 0.5× 63 0.5× 88 1.6× 38 0.8× 29 410
Leroy E. Cohen United States 6 153 0.5× 165 0.6× 77 0.6× 48 0.9× 15 0.3× 7 372
Nonkqubela Bantubani South Africa 6 486 1.5× 391 1.4× 140 1.1× 25 0.5× 35 0.7× 7 555
Cheuk‐Ming Tam China 11 309 0.9× 264 0.9× 126 1.0× 13 0.2× 5 0.1× 13 482

Countries citing papers authored by L. Uiso

Since Specialization
Citations

This map shows the geographic impact of L. Uiso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Uiso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Uiso more than expected).

Fields of papers citing papers by L. Uiso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Uiso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Uiso. The network helps show where L. Uiso may publish in the future.

Co-authorship network of co-authors of L. Uiso

This figure shows the co-authorship network connecting the top 25 collaborators of L. Uiso. A scholar is included among the top collaborators of L. Uiso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Uiso. L. Uiso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Crump, John A., Habib O. Ramadhani, L. Uiso, et al.. (2009). Early versus Delayed Fixed Dose Combination Abacavir/Lamivudine/Zidovudine in Patients with HIV and Tuberculosis in Tanzania. AIDS Research and Human Retroviruses. 25(12). 1277–1285. 18 indexed citations
2.
Seshadri, Chetan, L. Uiso, Jan Ostermann, et al.. (2008). Low Sensitivity of T-Cell Based Detection of Tuberculosis among HIV Co-Infected Tanzanian In-Patients. East African Medical Journal. 85(9). 442–442. 8 indexed citations
3.
McHugh, Timothy D., et al.. (2005). Mycobacterium tuberculosis lineage: A naming of the parts. Tuberculosis. 85(3). 127–136. 11 indexed citations
4.
Gillespie, Stephen H., Roly Gosling, L. Uiso, et al.. (2005). Early bactericidal activity of a moxifloxacin and isoniazid combination in smear-positive pulmonary tuberculosis. Journal of Antimicrobial Chemotherapy. 56(6). 1169–1171. 31 indexed citations
5.
Gosling, Roly, L. Uiso, Noel E. Sam, et al.. (2003). The Bactericidal Activity of Moxifloxacin in Patients with Pulmonary Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 168(11). 1342–1345. 119 indexed citations
6.
Kennedy, N., et al.. (1996). Nutritional status and weight gain in patients with pulmonary tuberculosis in Tanzania. Transactions of the Royal Society of Tropical Medicine and Hygiene. 90(2). 162–166. 78 indexed citations
7.
Kennedy, N., L. Berger, J. Curram, et al.. (1996). Randomized Controlled Trial of a Drug Regimen That Includes Ciproftoxacin for the Treatment of Pulmonary Tuberculosis. Clinical Infectious Diseases. 22(5). 827–833. 68 indexed citations
8.
Kennedy, N., et al.. (1995). Clinical Features and Serum β2-Microglobulin Levels in HIV-1 Positive and Negative Tanzanian Patients with Tuberculosis. International Journal of STD & AIDS. 6(4). 278–283. 5 indexed citations
9.
Kennedy, N., Roy Fox, L. Uiso, F.I. Ngowi, & Stephen H. Gillespie. (1993). Safety profile of ciprofloxacin during long-term therapy for pulmonary tuberculosis. Journal of Antimicrobial Chemotherapy. 32(6). 897–902. 18 indexed citations
10.
Kennedy, N., Ray Fox, L. Uiso, et al.. (1993). Early Bactericidal and Sterilizing Activities of Ciprofloxacin in Pulmonary Tuberculosis. American Review of Respiratory Disease. 148(6_pt_1). 1547–1551. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026